Our clients throughout Pennsylvania consistently report remarkable improvements in their overall wellness after experiencing this powerful treatment
Lotosky, J., Jean, X., Altankhuyag, A., Khan, S., Bernotas, A., Sharafshah, A., Blum, K., Posner, A., & Thanos, P
Why This Matters Reduced GLP-1 activity may show up as: Increased hunger or cravings Difficulty losing weight Rising fasting glucose or A1c Feeling like metabolism is working against you This is one reason many people are now prescribed GLP-1 medications alongside statins they help replace a pathway that may be underperforming
Dulaglutide (brand name Trulicity) is a long-acting GLP-1 receptor agonist approved by the FDA in 2014 for adults with type 2 diabetes, and later for cardiovascular risk reduction in people with established or high cardiovascular risk
For these reasons, GLP-1 analogues have been FDA-approved for treatment of obesity and diabetes, Dr